Daisuke Yamajuku

Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice

Atsuo Tahara, Eiji Kurosaki, Masanori Yokono et al. · European Journal of Pharmacology · 2013 · 305 citations

Obesity, Metabolic Syndrome, Inflammation +10

Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats

Atsuo Tahara, Eiji Kurosaki, Masanori Yokono et al. · Journal of Pharmacy and Pharmacology · 2014 · 122 citations

Real-time monitoring in three-dimensional hepatocytes reveals that insulin acts as a synchronizer for liver clock

Daisuke Yamajuku, Takahiko Inagaki, Tomonori Haruma et al. · Scientific Reports · 2012 · 117 citations · Full text

Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo

Atsuo Tahara, Eiji Kurosaki, Masanori Yokono et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2011 · 106 citations

Anti-inflammatory, Allergy, Medicine +7

Cellular DBP and E4BP4 proteins are critical for determining the period length of the circadian oscillator

Daisuke Yamajuku, Yasutaka Shibata, Masashi Kitazawa et al. · FEBS Letters · 2011 · 66 citations

Clock Gene Mutations, Signal Recognition, Molecular Biology +20